Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sox6
|
ENSMUSG00000051910.7 | SRY (sex determining region Y)-box 6 |
Sox9
|
ENSMUSG00000000567.5 | SRY (sex determining region Y)-box 9 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_115722131_115722282 | Sox6 | 59841 | 0.154957 | 0.76 | 1.1e-11 | Click! |
chr7_115895386_115895546 | Sox6 | 35614 | 0.195001 | -0.72 | 5.5e-10 | Click! |
chr7_115798710_115798861 | Sox6 | 25925 | 0.252712 | -0.71 | 1.6e-09 | Click! |
chr7_115845858_115846040 | Sox6 | 156 | 0.974952 | -0.68 | 9.9e-09 | Click! |
chr7_115830920_115831237 | Sox6 | 6368 | 0.310099 | -0.68 | 1.2e-08 | Click! |
chr11_112784651_112785315 | Sox9 | 2759 | 0.235958 | 0.44 | 7.7e-04 | Click! |
chr11_112785379_112785530 | Sox9 | 3230 | 0.221219 | 0.42 | 1.5e-03 | Click! |
chr11_112783413_112783564 | Sox9 | 1264 | 0.365289 | 0.41 | 1.9e-03 | Click! |
chr11_112782013_112782269 | Sox9 | 83 | 0.618446 | 0.39 | 3.4e-03 | Click! |
chr11_112782356_112782987 | Sox9 | 447 | 0.611405 | 0.35 | 9.5e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_109874355_109874582 | 17.52 |
Gm44162 |
predicted gene, 44162 |
158921 |
0.04 |
chr9_36821327_36821662 | 12.30 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
370 |
0.82 |
chr15_73021189_73021788 | 11.99 |
Trappc9 |
trafficking protein particle complex 9 |
34322 |
0.18 |
chr3_17785697_17785901 | 10.75 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
4122 |
0.22 |
chr19_17492246_17492464 | 10.15 |
Rfk |
riboflavin kinase |
94918 |
0.08 |
chr14_24617341_24617911 | 9.79 |
4930428N03Rik |
RIKEN cDNA 4930428N03 gene |
58 |
0.64 |
chr4_72233972_72234136 | 9.14 |
C630043F03Rik |
RIKEN cDNA C630043F03 gene |
32706 |
0.18 |
chr11_32157683_32158170 | 9.01 |
Gm12109 |
predicted gene 12109 |
27079 |
0.12 |
chr6_55920513_55920755 | 8.90 |
Itprid1 |
ITPR interacting domain containing 1 |
33809 |
0.21 |
chr13_73034418_73035007 | 8.87 |
Rpl31-ps2 |
ribosomal protein L31, pseudogene 2 |
198683 |
0.02 |
chr1_47278444_47278595 | 8.82 |
Gm4852 |
predicted pseudogene 4852 |
87853 |
0.09 |
chr10_38553865_38554067 | 8.72 |
Gm22911 |
predicted gene, 22911 |
61515 |
0.14 |
chr11_14181939_14182516 | 8.61 |
4930554G24Rik |
RIKEN cDNA 4930554G24 gene |
3186 |
0.33 |
chr17_13589870_13590228 | 8.17 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
21185 |
0.15 |
chr19_36534720_36535517 | 7.72 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
19521 |
0.2 |
chr7_96718538_96719200 | 7.70 |
Tenm4 |
teneurin transmembrane protein 4 |
59065 |
0.11 |
chr14_93083221_93083444 | 7.62 |
Gm23509 |
predicted gene, 23509 |
54857 |
0.15 |
chr6_89613728_89614091 | 7.56 |
Chchd6 |
coiled-coil-helix-coiled-coil-helix domain containing 6 |
18257 |
0.17 |
chr9_84253597_84253862 | 7.51 |
Gm26146 |
predicted gene, 26146 |
65374 |
0.12 |
chr2_52946485_52946700 | 7.41 |
Fmnl2 |
formin-like 2 |
88724 |
0.09 |
chr7_62416271_62416450 | 7.38 |
Mkrn3 |
makorin, ring finger protein, 3 |
3779 |
0.19 |
chr2_137092072_137092235 | 7.34 |
Jag1 |
jagged 1 |
6204 |
0.3 |
chr8_45875083_45875615 | 7.28 |
Pdlim3 |
PDZ and LIM domain 3 |
10112 |
0.13 |
chr7_90843662_90843846 | 7.27 |
A930002H02Rik |
RIKEN cDNA A930002H02 gene |
27849 |
0.15 |
chr13_84056571_84056869 | 7.13 |
Gm17750 |
predicted gene, 17750 |
8052 |
0.22 |
chr18_68140582_68141045 | 6.93 |
Gm41764 |
predicted gene, 41764 |
22439 |
0.18 |
chr9_16437769_16438174 | 6.84 |
Gm48726 |
predicted gene, 48726 |
2576 |
0.4 |
chr10_28493360_28493585 | 6.83 |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
66679 |
0.13 |
chr9_41374538_41374703 | 6.82 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1689 |
0.35 |
chr2_14823795_14824119 | 6.77 |
Cacnb2 |
calcium channel, voltage-dependent, beta 2 subunit |
69 |
0.97 |
chr10_84710909_84711119 | 6.73 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
45048 |
0.13 |
chr18_49445578_49445977 | 6.66 |
1700044K03Rik |
RIKEN cDNA 1700044K03 gene |
77512 |
0.11 |
chr8_45508006_45508255 | 6.62 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
212 |
0.94 |
chr2_142164292_142164571 | 6.61 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
12176 |
0.32 |
chr14_122453111_122453347 | 6.57 |
Gm5089 |
predicted gene 5089 |
2114 |
0.21 |
chr18_44744615_44744788 | 6.54 |
Mcc |
mutated in colorectal cancers |
20043 |
0.2 |
chrX_100767116_100767479 | 6.52 |
Dlg3 |
discs large MAGUK scaffold protein 3 |
425 |
0.8 |
chr10_92165069_92165271 | 6.51 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
0 |
0.98 |
chr6_94631259_94631471 | 6.51 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
24160 |
0.17 |
chr6_145585388_145585553 | 6.50 |
Lmntd1 |
lamin tail domain containing 1 |
28499 |
0.17 |
chr10_30405975_30406418 | 6.43 |
Gm4780 |
predicted gene 4780 |
32923 |
0.18 |
chr3_69406431_69406599 | 6.41 |
Gm17213 |
predicted gene 17213 |
25853 |
0.18 |
chr1_78141770_78141940 | 6.41 |
Pax3 |
paired box 3 |
54983 |
0.14 |
chr3_20986980_20987301 | 6.39 |
Gm7488 |
predicted gene 7488 |
62425 |
0.13 |
chr4_25408022_25408173 | 6.36 |
Gm11894 |
predicted gene 11894 |
11252 |
0.22 |
chr8_47243033_47243379 | 6.35 |
Stox2 |
storkhead box 2 |
520 |
0.81 |
chr13_28419934_28420350 | 6.34 |
Gm40841 |
predicted gene, 40841 |
76 |
0.98 |
chr5_21732375_21732598 | 6.32 |
Pmpcb |
peptidase (mitochondrial processing) beta |
4655 |
0.15 |
chr4_25768890_25769041 | 6.29 |
Fut9 |
fucosyltransferase 9 |
30890 |
0.17 |
chr4_82304607_82304811 | 6.28 |
n-R5s188 |
nuclear encoded rRNA 5S 188 |
134701 |
0.05 |
chr8_124284305_124284745 | 6.25 |
Galnt2 |
polypeptide N-acetylgalactosaminyltransferase 2 |
10578 |
0.17 |
chr2_146221890_146222279 | 6.23 |
Insm1 |
insulinoma-associated 1 |
163 |
0.95 |
chr7_4123736_4124170 | 6.22 |
Ttyh1 |
tweety family member 1 |
536 |
0.57 |
chr7_73192018_73192207 | 6.18 |
Gm20083 |
predicted gene, 20083 |
6309 |
0.17 |
chr15_98951811_98951974 | 6.18 |
Gm49450 |
predicted gene, 49450 |
1659 |
0.16 |
chr9_61468387_61468621 | 6.17 |
Gm47240 |
predicted gene, 47240 |
4482 |
0.22 |
chr3_157321061_157321436 | 6.15 |
Gm22458 |
predicted gene, 22458 |
44750 |
0.14 |
chr7_19171755_19171906 | 6.13 |
Eml2 |
echinoderm microtubule associated protein like 2 |
4591 |
0.09 |
chr14_12821852_12822433 | 6.11 |
Cadps |
Ca2+-dependent secretion activator |
903 |
0.65 |
chr3_18206079_18206269 | 6.10 |
Gm23686 |
predicted gene, 23686 |
28549 |
0.18 |
chr10_109684839_109685035 | 6.10 |
3110043J17Rik |
RIKEN cDNA 3110043J17 gene |
36158 |
0.19 |
chr4_72233724_72233875 | 6.08 |
C630043F03Rik |
RIKEN cDNA C630043F03 gene |
32451 |
0.18 |
chr12_90274736_90274906 | 6.05 |
Gm2270 |
predicted gene 2270 |
89431 |
0.09 |
chr18_69624676_69624827 | 6.01 |
Tcf4 |
transcription factor 4 |
12307 |
0.27 |
chr4_56492993_56493204 | 6.01 |
Gm12518 |
predicted gene 12518 |
105296 |
0.07 |
chr19_15615004_15615349 | 6.00 |
Gm24319 |
predicted gene, 24319 |
64828 |
0.14 |
chr19_18102052_18102204 | 5.99 |
Gm50182 |
predicted gene, 50182 |
74017 |
0.11 |
chr9_71879542_71879779 | 5.95 |
Tcf12 |
transcription factor 12 |
5051 |
0.13 |
chr10_52742737_52743261 | 5.95 |
Gm47624 |
predicted gene, 47624 |
49161 |
0.11 |
chr13_105250811_105251272 | 5.95 |
Rnf180 |
ring finger protein 180 |
19998 |
0.22 |
chr7_18948259_18948454 | 5.94 |
Nova2 |
NOVA alternative splicing regulator 2 |
22468 |
0.08 |
chr4_97476907_97477141 | 5.92 |
Gm12696 |
predicted gene 12696 |
45308 |
0.18 |
chr14_67537122_67537330 | 5.86 |
Gm24981 |
predicted gene, 24981 |
29624 |
0.16 |
chr10_121882590_121882741 | 5.84 |
Gm48804 |
predicted gene, 48804 |
50607 |
0.13 |
chr10_125961290_125962183 | 5.82 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
4432 |
0.33 |
chr15_66239660_66240017 | 5.79 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
46213 |
0.14 |
chr5_30106799_30107171 | 5.77 |
3110082J24Rik |
RIKEN cDNA 3110082J24 gene |
899 |
0.4 |
chr10_6124533_6124701 | 5.76 |
Rgs17 |
regulator of G-protein signaling 17 |
202217 |
0.03 |
chr8_118004676_118004840 | 5.75 |
Gm25200 |
predicted gene, 25200 |
116196 |
0.06 |
chr1_179446474_179446863 | 5.74 |
Smyd3 |
SET and MYND domain containing 3 |
41249 |
0.16 |
chr2_94035739_94036005 | 5.72 |
Alkbh3 |
alkB homolog 3, alpha-ketoglutarate-dependent dioxygenase |
25065 |
0.14 |
chr11_34941721_34941954 | 5.71 |
Gm25799 |
predicted gene, 25799 |
42820 |
0.16 |
chr1_168046666_168046867 | 5.71 |
Gm20711 |
predicted gene 20711 |
42627 |
0.2 |
chr16_33605736_33606716 | 5.71 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr3_17327769_17327995 | 5.69 |
Gm30340 |
predicted gene, 30340 |
6543 |
0.24 |
chr12_53915814_53915965 | 5.66 |
1700060O08Rik |
RIKEN cDNA 1700060O08 gene |
163503 |
0.04 |
chr18_19603967_19604152 | 5.65 |
Gm7720 |
predicted gene 7720 |
49099 |
0.19 |
chr5_44538768_44538919 | 5.65 |
Ldb2 |
LIM domain binding 2 |
3746 |
0.17 |
chr3_5237922_5238073 | 5.64 |
Zfhx4 |
zinc finger homeodomain 4 |
3675 |
0.25 |
chrX_18461302_18461622 | 5.62 |
Dipk2b |
divergent protein kinase domain 2B |
65 |
0.99 |
chr15_98983244_98983754 | 5.61 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
128 |
0.91 |
chr8_48224421_48225088 | 5.58 |
Gm32842 |
predicted gene, 32842 |
46231 |
0.16 |
chr2_73782320_73782924 | 5.56 |
Chn1 |
chimerin 1 |
7276 |
0.21 |
chr3_108432963_108433388 | 5.56 |
Gm22942 |
predicted gene, 22942 |
8155 |
0.09 |
chr14_24827369_24827565 | 5.54 |
Gm47906 |
predicted gene, 47906 |
6168 |
0.28 |
chr6_78551794_78551955 | 5.53 |
Gm6072 |
predicted gene 6072 |
54433 |
0.13 |
chr1_93101519_93102308 | 5.53 |
Kif1a |
kinesin family member 1A |
38 |
0.97 |
chr1_77629974_77630266 | 5.50 |
Gm28385 |
predicted gene 28385 |
59448 |
0.14 |
chr8_94996936_94997262 | 5.49 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
1438 |
0.29 |
chr11_68391059_68391219 | 5.48 |
Ntn1 |
netrin 1 |
4127 |
0.26 |
chr15_69303244_69303395 | 5.46 |
4930504C09Rik |
RIKEN cDNA 4930504C09 gene |
32786 |
0.21 |
chr19_36002847_36002998 | 5.45 |
Htr7 |
5-hydroxytryptamine (serotonin) receptor 7 |
54418 |
0.13 |
chr12_49945023_49945183 | 5.45 |
Gm7481 |
predicted gene 7481 |
103352 |
0.08 |
chr14_21368750_21368912 | 5.42 |
Adk |
adenosine kinase |
239 |
0.95 |
chr3_94477953_94478530 | 5.42 |
Celf3 |
CUGBP, Elav-like family member 3 |
54 |
0.93 |
chr19_36534473_36534683 | 5.41 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
20061 |
0.2 |
chr10_39541021_39541386 | 5.41 |
Fyn |
Fyn proto-oncogene |
7933 |
0.19 |
chr2_174917610_174917806 | 5.40 |
Gm14616 |
predicted gene 14616 |
61419 |
0.09 |
chr7_79535477_79536145 | 5.37 |
Gm35040 |
predicted gene, 35040 |
232 |
0.85 |
chr6_5380998_5381157 | 5.37 |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
2309 |
0.37 |
chr3_17790108_17790687 | 5.37 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
440 |
0.82 |
chr2_154465967_154466138 | 5.33 |
Cbfa2t2 |
CBFA2/RUNX1 translocation partner 2 |
29210 |
0.13 |
chr11_32002527_32003111 | 5.32 |
Nsg2 |
neuron specific gene family member 2 |
2317 |
0.33 |
chr15_10746665_10746863 | 5.30 |
4930556M19Rik |
RIKEN cDNA 4930556M19 gene |
28913 |
0.16 |
chr8_23596316_23596734 | 5.28 |
Zmat4 |
zinc finger, matrin type 4 |
39494 |
0.19 |
chr18_28078450_28078648 | 5.28 |
Gm5064 |
predicted gene 5064 |
110268 |
0.07 |
chr16_22800440_22800662 | 5.27 |
Crygs |
crystallin, gamma S |
11026 |
0.16 |
chr1_98190760_98191093 | 5.25 |
Gm29461 |
predicted gene 29461 |
17278 |
0.2 |
chr14_118230141_118230337 | 5.25 |
Gm4675 |
predicted gene 4675 |
5993 |
0.14 |
chr6_127404014_127404362 | 5.23 |
Gm34091 |
predicted gene, 34091 |
6942 |
0.17 |
chr4_28300161_28300466 | 5.21 |
Gm11907 |
predicted gene 11907 |
53470 |
0.15 |
chr14_66319931_66320237 | 5.20 |
Gm41183 |
predicted gene, 41183 |
21145 |
0.13 |
chr1_54640255_54640417 | 5.18 |
Ankrd44 |
ankyrin repeat domain 44 |
8277 |
0.2 |
chr12_34528890_34529067 | 5.18 |
Hdac9 |
histone deacetylase 9 |
104 |
0.98 |
chr19_26770137_26770516 | 5.18 |
Smarca2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
165 |
0.96 |
chr10_37626746_37626910 | 5.17 |
Gm48172 |
predicted gene, 48172 |
174148 |
0.03 |
chr6_127769996_127770149 | 5.17 |
Prmt8 |
protein arginine N-methyltransferase 8 |
600 |
0.57 |
chr14_59737148_59737645 | 5.16 |
Gm19716 |
predicted gene, 19716 |
94848 |
0.07 |
chr13_99458740_99458927 | 5.15 |
Map1b |
microtubule-associated protein 1B |
11213 |
0.18 |
chr3_34649198_34650117 | 5.15 |
Sox2 |
SRY (sex determining region Y)-box 2 |
748 |
0.5 |
chr19_42409134_42409463 | 5.14 |
Gm34299 |
predicted gene, 34299 |
1096 |
0.49 |
chr3_147182011_147182302 | 5.14 |
Gm6074 |
predicted gene 6074 |
10762 |
0.28 |
chr13_69260577_69260855 | 5.13 |
Gm4812 |
predicted gene 4812 |
84939 |
0.08 |
chr19_12493775_12494134 | 5.13 |
Dtx4 |
deltex 4, E3 ubiquitin ligase |
7500 |
0.11 |
chr5_45173458_45173609 | 5.13 |
D5Ertd615e |
DNA segment, Chr 5, ERATO Doi 615, expressed |
2160 |
0.38 |
chr4_3067329_3068553 | 5.12 |
Gm27878 |
predicted gene, 27878 |
16122 |
0.2 |
chr12_41647214_41647445 | 5.09 |
Gm47369 |
predicted gene, 47369 |
37065 |
0.2 |
chr5_13982707_13982992 | 5.08 |
Sema3e |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
42427 |
0.13 |
chr4_122999274_122999698 | 5.08 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
147 |
0.94 |
chr12_13083454_13083605 | 5.06 |
Gm35298 |
predicted gene, 35298 |
19316 |
0.15 |
chr4_32530550_32530721 | 5.04 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
29130 |
0.16 |
chr16_44679983_44680134 | 5.02 |
Nepro |
nucleolus and neural progenitor protein |
44243 |
0.13 |
chr9_92930513_92930898 | 5.02 |
Gm28054 |
predicted gene 28054 |
34873 |
0.17 |
chr8_35606070_35606252 | 4.97 |
Mfhas1 |
malignant fibrous histiocytoma amplified sequence 1 |
1116 |
0.51 |
chr10_13108416_13108609 | 4.94 |
Plagl1 |
pleiomorphic adenoma gene-like 1 |
4953 |
0.23 |
chr13_104517962_104518622 | 4.92 |
2610204G07Rik |
RIKEN cDNA 2610204G07 gene |
166639 |
0.03 |
chr5_46756311_46756488 | 4.91 |
Gm43092 |
predicted gene 43092 |
38281 |
0.23 |
chr5_9622835_9622986 | 4.90 |
Gm42455 |
predicted gene 42455 |
20303 |
0.24 |
chr10_106609605_106610022 | 4.89 |
4930532I03Rik |
RIKEN cDNA 4930532I03 gene |
7333 |
0.29 |
chr17_93676683_93676842 | 4.88 |
Gm50002 |
predicted gene, 50002 |
3903 |
0.28 |
chr1_6734835_6735004 | 4.88 |
St18 |
suppression of tumorigenicity 18 |
49 |
0.99 |
chr13_83732174_83732508 | 4.87 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
225 |
0.89 |
chr18_64014262_64014492 | 4.87 |
Gm6974 |
predicted gene 6974 |
67043 |
0.1 |
chr11_32162265_32162460 | 4.85 |
Gm12109 |
predicted gene 12109 |
22643 |
0.12 |
chr5_110997258_110997442 | 4.84 |
Mir701 |
microRNA 701 |
6794 |
0.15 |
chr8_26678010_26678194 | 4.83 |
Gm32098 |
predicted gene, 32098 |
9796 |
0.18 |
chr2_170836919_170837070 | 4.82 |
Dok5 |
docking protein 5 |
105187 |
0.07 |
chr11_52661359_52661514 | 4.80 |
Fstl4 |
follistatin-like 4 |
103198 |
0.07 |
chr2_49619461_49620115 | 4.79 |
Kif5c |
kinesin family member 5C |
490 |
0.86 |
chr4_21686074_21686336 | 4.76 |
Prdm13 |
PR domain containing 13 |
242 |
0.92 |
chr9_41735663_41735856 | 4.75 |
Gm35835 |
predicted gene, 35835 |
1621 |
0.37 |
chr6_17796921_17797464 | 4.74 |
Gm26738 |
predicted gene, 26738 |
37993 |
0.12 |
chr11_36677713_36677995 | 4.69 |
Tenm2 |
teneurin transmembrane protein 2 |
109 |
0.98 |
chr2_157975223_157975410 | 4.68 |
Tti1 |
TELO2 interacting protein 1 |
31896 |
0.14 |
chr6_103558666_103559112 | 4.67 |
Gm44441 |
predicted gene, 44441 |
5467 |
0.16 |
chr13_26932721_26933068 | 4.67 |
Gm11355 |
predicted gene 11355 |
32898 |
0.18 |
chr9_49796724_49798126 | 4.66 |
Ncam1 |
neural cell adhesion molecule 1 |
1333 |
0.53 |
chr3_5755500_5755721 | 4.66 |
Gm8797 |
predicted pseudogene 8797 |
4804 |
0.31 |
chr17_8368062_8368258 | 4.63 |
T2 |
brachyury 2 |
4236 |
0.14 |
chr13_49706394_49706579 | 4.62 |
Iars |
isoleucine-tRNA synthetase |
71 |
0.95 |
chr4_41611662_41611813 | 4.62 |
Dnaic1 |
dynein, axonemal, intermediate chain 1 |
19907 |
0.09 |
chr8_94154535_94154978 | 4.61 |
Mt3 |
metallothionein 3 |
2010 |
0.19 |
chr18_16037927_16038695 | 4.61 |
Gm4835 |
predicted pseudogene 4835 |
49943 |
0.17 |
chr15_59154383_59154907 | 4.61 |
Rpl7-ps8 |
ribosomal protein L7, pseudogene 8 |
56263 |
0.11 |
chr10_46826123_46826274 | 4.60 |
Gm25650 |
predicted gene, 25650 |
12309 |
0.24 |
chr11_43559943_43560166 | 4.60 |
Gm12150 |
predicted gene 12150 |
21062 |
0.12 |
chrX_60719671_60720024 | 4.59 |
Gm8163 |
predicted gene 8163 |
7601 |
0.2 |
chr7_64539826_64540048 | 4.57 |
Gm44721 |
predicted gene 44721 |
10512 |
0.19 |
chr13_110280472_110281172 | 4.57 |
Rab3c |
RAB3C, member RAS oncogene family |
79 |
0.98 |
chr9_52149332_52149692 | 4.56 |
Zc3h12c |
zinc finger CCCH type containing 12C |
18599 |
0.18 |
chr11_32087496_32088333 | 4.55 |
Gm12108 |
predicted gene 12108 |
13314 |
0.2 |
chr9_16498920_16499190 | 4.55 |
Fat3 |
FAT atypical cadherin 3 |
2230 |
0.44 |
chr4_98108669_98109025 | 4.55 |
Gm12691 |
predicted gene 12691 |
37752 |
0.2 |
chr8_45734198_45734373 | 4.55 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
8896 |
0.2 |
chr18_37849566_37850014 | 4.54 |
Diaph1 |
diaphanous related formin 1 |
3617 |
0.09 |
chr3_5327075_5327408 | 4.54 |
Zfhx4 |
zinc finger homeodomain 4 |
85569 |
0.09 |
chr5_112239158_112239879 | 4.54 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
10123 |
0.11 |
chr10_96755718_96755869 | 4.54 |
Gm6859 |
predicted gene 6859 |
14035 |
0.18 |
chr3_139023701_139023892 | 4.53 |
Rap1gds1 |
RAP1, GTP-GDP dissociation stimulator 1 |
39259 |
0.16 |
chr3_121700086_121700284 | 4.52 |
Gm43608 |
predicted gene 43608 |
10061 |
0.11 |
chr2_28525282_28526472 | 4.50 |
Ralgds |
ral guanine nucleotide dissociation stimulator |
1973 |
0.2 |
chr3_17796321_17796503 | 4.49 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
668 |
0.46 |
chr4_22835787_22836371 | 4.46 |
Gm24078 |
predicted gene, 24078 |
88948 |
0.09 |
chr13_83749344_83749514 | 4.46 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
10566 |
0.12 |
chr9_42173888_42174039 | 4.46 |
Gm39321 |
predicted gene, 39321 |
31602 |
0.14 |
chr16_43623692_43623859 | 4.46 |
Mir568 |
microRNA 568 |
16880 |
0.18 |
chr8_67086383_67086534 | 4.45 |
Gm7639 |
predicted gene 7639 |
32325 |
0.19 |
chr18_47609051_47609244 | 4.45 |
Gm5095 |
predicted gene 5095 |
71412 |
0.1 |
chr2_165043149_165043683 | 4.45 |
Ncoa5 |
nuclear receptor coactivator 5 |
8549 |
0.14 |
chr6_17142993_17143144 | 4.44 |
Gm4876 |
predicted gene 4876 |
28397 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.9 | 8.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.6 | 7.9 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.4 | 4.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.3 | 11.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
1.3 | 3.9 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.1 | 3.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.1 | 3.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.1 | 4.3 | GO:0061743 | motor learning(GO:0061743) |
1.1 | 9.6 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.1 | 12.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.0 | 3.1 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.0 | 4.0 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.0 | 4.0 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.0 | 2.0 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.0 | 3.0 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.0 | 3.9 | GO:0030035 | microspike assembly(GO:0030035) |
1.0 | 1.9 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.9 | 3.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.8 | 1.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.8 | 5.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.8 | 1.6 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.8 | 3.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.8 | 1.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.8 | 3.2 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.8 | 5.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.8 | 3.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.8 | 3.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.8 | 2.3 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.7 | 3.7 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.7 | 6.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.7 | 2.1 | GO:0015817 | histidine transport(GO:0015817) |
0.7 | 2.8 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.7 | 2.1 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.7 | 13.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.7 | 2.8 | GO:0010288 | response to lead ion(GO:0010288) |
0.7 | 2.8 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.7 | 2.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.7 | 2.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.7 | 4.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.7 | 4.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.7 | 2.7 | GO:0060594 | mammary gland specification(GO:0060594) |
0.7 | 2.0 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.6 | 1.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.6 | 1.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.6 | 1.8 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.6 | 1.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.6 | 2.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.6 | 2.3 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.6 | 1.7 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.6 | 2.8 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.6 | 2.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 3.8 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.5 | 1.6 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.5 | 0.5 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.5 | 0.5 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.5 | 4.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.5 | 1.6 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.5 | 0.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.5 | 5.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.5 | 0.5 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.5 | 2.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.5 | 1.5 | GO:0030070 | insulin processing(GO:0030070) |
0.5 | 2.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.5 | 1.5 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.5 | 1.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.5 | 1.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.5 | 0.5 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.5 | 2.9 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.5 | 3.9 | GO:0060539 | diaphragm development(GO:0060539) |
0.5 | 2.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.5 | 2.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.5 | 2.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.5 | 0.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.5 | 1.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.5 | 0.9 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.5 | 0.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.5 | 4.6 | GO:0060013 | righting reflex(GO:0060013) |
0.5 | 0.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 0.5 | GO:0060596 | mammary placode formation(GO:0060596) |
0.5 | 0.9 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.5 | 2.3 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.5 | 1.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.4 | 1.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 1.3 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.4 | 1.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.4 | 0.9 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.4 | 0.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.4 | 4.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.4 | 1.8 | GO:0007412 | axon target recognition(GO:0007412) |
0.4 | 0.9 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.4 | 0.4 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.4 | 1.7 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.4 | 2.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 0.4 | GO:1902946 | protein localization to early endosome(GO:1902946) |
0.4 | 1.3 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.4 | 0.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 1.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.4 | 8.6 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.4 | 2.0 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 5.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 1.2 | GO:0048840 | otolith development(GO:0048840) |
0.4 | 1.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 1.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.4 | 1.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.4 | 2.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 0.4 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.4 | 0.7 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.4 | 0.7 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 6.9 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.4 | 1.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.4 | 0.4 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.4 | 1.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 1.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.4 | 1.4 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.4 | 1.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 0.7 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.3 | 1.0 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.3 | 0.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.3 | 1.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.3 | 1.0 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.3 | 0.7 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 5.0 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 1.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 1.0 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.3 | 1.0 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.3 | 1.0 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.3 | 1.0 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.3 | 1.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 0.3 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.3 | 0.3 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.3 | 3.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 1.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.3 | 1.0 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.3 | 1.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 0.9 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.3 | 0.6 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.3 | 0.9 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.3 | 1.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.3 | 0.6 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 0.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 0.3 | GO:0048382 | mesendoderm development(GO:0048382) |
0.3 | 0.9 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.3 | 1.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 1.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 1.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 1.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 1.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 0.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 1.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 0.6 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.3 | 0.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 4.5 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.3 | 0.3 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) |
0.3 | 1.7 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.3 | 4.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 0.5 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.3 | 0.8 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.3 | 1.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 2.2 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.3 | 1.1 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.3 | 0.8 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.3 | 0.5 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 1.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 | 0.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.3 | 0.8 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.3 | 3.9 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.3 | 0.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 0.8 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.3 | 0.8 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.3 | 4.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 0.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 0.8 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 1.2 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.2 | 0.2 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.2 | 0.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 0.5 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.2 | 1.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 2.2 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.2 | 0.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 2.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 3.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 1.7 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.2 | 0.7 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.2 | 3.1 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 0.7 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 0.9 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 4.5 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 1.4 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.2 | 0.9 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.2 | 0.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 0.7 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.2 | 0.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.9 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.5 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.2 | 2.5 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.2 | 0.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 2.9 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.2 | 0.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 3.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 1.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.2 | 0.4 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
0.2 | 0.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.2 | 0.2 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
0.2 | 0.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.7 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 1.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 1.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 0.9 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 2.4 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 0.4 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
0.2 | 1.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 2.1 | GO:0042711 | maternal behavior(GO:0042711) |
0.2 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 0.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.8 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.8 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.2 | 0.4 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 2.6 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 0.6 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.2 | 0.6 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.2 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.2 | 0.6 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 0.6 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 0.6 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.2 | 0.2 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.2 | 0.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.2 | 0.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.6 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 0.6 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.8 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.2 | 0.6 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.9 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.2 | 0.9 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 0.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.2 | 0.9 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.2 | 0.2 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.2 | 1.1 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.2 | 2.0 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.2 | 1.8 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.4 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.2 | 1.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.2 | 2.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 1.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 1.0 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.2 | 1.0 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 1.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.9 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 1.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 0.2 | GO:1901629 | regulation of presynaptic membrane organization(GO:1901629) |
0.2 | 0.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.2 | 0.5 | GO:0019230 | proprioception(GO:0019230) |
0.2 | 0.5 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.2 | 0.2 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.2 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 2.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.2 | 0.3 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.2 | 0.2 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.2 | 0.3 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 1.6 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 1.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 1.0 | GO:0045779 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.2 | 1.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.2 | 0.2 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 0.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.2 | 0.6 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.6 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.2 | 0.6 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 0.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 2.8 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 1.7 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.2 | 0.3 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.2 | 0.8 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.2 | 0.6 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 7.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.4 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.7 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.3 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.9 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.7 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.7 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.4 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.7 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.4 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.3 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.7 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.3 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.1 | 0.1 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.1 | 0.4 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 0.1 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.4 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.3 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.1 | 2.9 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.4 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.1 | 1.4 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.4 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 3.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 1.5 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 1.5 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.5 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.3 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 1.0 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.8 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 1.1 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.1 | 0.3 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.1 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.1 | 0.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 1.9 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.5 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.4 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.4 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.2 | GO:0035483 | gastric emptying(GO:0035483) |
0.1 | 0.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.4 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 0.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 4.2 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 1.5 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.1 | 0.2 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.1 | 0.7 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 0.2 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.1 | 0.3 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.1 | 0.9 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.3 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 1.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.2 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 1.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 3.0 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 2.7 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.3 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.4 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.1 | GO:0045472 | response to ether(GO:0045472) |
0.1 | 0.1 | GO:0090427 | activation of meiosis(GO:0090427) |
0.1 | 0.4 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 0.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.1 | 0.7 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.7 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.6 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.3 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.1 | 0.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.1 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.1 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.3 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 2.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 1.0 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.6 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.6 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.4 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.1 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.1 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.5 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.1 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
0.1 | 0.3 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) dendritic spine organization(GO:0097061) |
0.1 | 0.2 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.1 | 0.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.2 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.1 | 0.3 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 1.0 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.2 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.1 | 0.2 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.1 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.1 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.1 | 0.3 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.2 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.4 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.1 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.1 | 0.2 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.6 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.2 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.1 | 0.2 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 0.2 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0021544 | subpallium development(GO:0021544) |
0.1 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.5 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 2.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.5 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.1 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.5 | GO:0035640 | exploration behavior(GO:0035640) |
0.1 | 0.1 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.3 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.3 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 0.6 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.1 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.3 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.2 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.1 | 1.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.3 | GO:0060421 | positive regulation of heart growth(GO:0060421) |
0.1 | 0.1 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.5 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.1 | GO:0061196 | fungiform papilla development(GO:0061196) |
0.1 | 0.8 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 | 0.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.4 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.4 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 1.3 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.2 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.0 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.5 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.5 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.1 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.0 | 0.2 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.0 | 0.3 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.5 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 2.9 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 1.5 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 0.0 | GO:1902415 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.0 | 0.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.0 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.0 | 0.4 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.1 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.0 | 0.2 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.2 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.0 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.0 | 0.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.5 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.2 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.0 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.4 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.8 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.1 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.0 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.2 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.0 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.0 | 0.1 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.1 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.3 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.0 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.0 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.1 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.0 | 0.1 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.0 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.0 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.0 | 0.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.0 | 0.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.1 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.0 | 0.4 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.0 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.3 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.0 | 0.0 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.0 | 0.0 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.0 | 0.2 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.1 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
0.0 | 0.1 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.0 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.0 | 0.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.0 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.0 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.1 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.0 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.0 | 0.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.3 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.0 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
0.0 | 1.2 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.0 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.0 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.3 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.0 | 0.0 | GO:0001975 | response to amphetamine(GO:0001975) |
0.0 | 0.0 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.0 | 0.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.2 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.0 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
0.0 | 0.4 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.1 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.0 | 0.0 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.0 | 0.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.0 | 0.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.0 | 0.0 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.0 | 1.4 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.0 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.2 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.0 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.0 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.0 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.0 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.0 | 0.0 | GO:0060438 | trachea development(GO:0060438) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.0 | 0.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 0.0 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.0 | 0.1 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.0 | 0.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.0 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.0 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.0 | 0.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.0 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.0 | 0.0 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.0 | GO:0021610 | facial nerve development(GO:0021561) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) |
0.0 | 0.0 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.0 | 0.1 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.0 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.0 | 0.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.0 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.1 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.1 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.0 | 0.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.0 | GO:1903423 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.0 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 11.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.0 | 3.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.9 | 3.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.9 | 10.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 2.8 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.6 | 1.8 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.6 | 4.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.6 | 1.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.6 | 2.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.6 | 2.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 4.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 1.9 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 1.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.5 | 1.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 4.6 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 3.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 0.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 5.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 1.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 3.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 2.8 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.3 | 1.0 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 0.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 1.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 0.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 0.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.3 | 2.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 0.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 1.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.3 | 2.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 3.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 0.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.3 | 0.8 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 1.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.3 | 3.7 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 6.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 0.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 4.5 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.2 | 5.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 1.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.7 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 7.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 0.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 1.4 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 1.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 0.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 1.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 2.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.7 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 0.5 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 0.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 4.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 1.6 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 1.4 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.9 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 2.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 1.6 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 4.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.6 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.9 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 6.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 1.1 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 2.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 1.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 8.8 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 3.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.9 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 1.1 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.7 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 3.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.5 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 8.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 15.4 | GO:0030425 | dendrite(GO:0030425) |
0.1 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 1.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 1.4 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 8.4 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.3 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 2.2 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 2.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.7 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 1.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 1.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.0 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 9.8 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
2.6 | 7.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.0 | 5.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.4 | 5.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.4 | 8.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.2 | 3.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.2 | 4.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.0 | 3.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.0 | 5.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.9 | 1.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.9 | 2.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.8 | 3.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.8 | 3.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.8 | 6.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.8 | 3.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.7 | 2.1 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.7 | 6.1 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.6 | 1.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 3.4 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.5 | 2.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.5 | 1.6 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.5 | 5.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.5 | 2.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 1.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.5 | 0.5 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.5 | 2.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.5 | 1.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.5 | 2.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.5 | 1.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.5 | 3.7 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.5 | 1.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.5 | 1.8 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.4 | 1.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 2.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 11.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.4 | 1.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 5.1 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.4 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 1.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 2.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.4 | 1.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.4 | 1.2 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.4 | 2.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.4 | 2.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.4 | 2.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 0.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 1.0 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.3 | 3.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 1.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 1.3 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 2.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 1.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 0.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 1.2 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.3 | 2.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 2.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 6.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 2.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 3.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 0.9 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 1.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 2.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 3.4 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.3 | 0.8 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 3.9 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 1.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 1.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.3 | 0.8 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 4.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 0.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 1.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 0.8 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 3.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 1.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 3.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 0.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 1.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 1.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 0.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 3.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 0.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 0.7 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 0.7 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 0.7 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 4.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 0.4 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 0.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 1.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 0.8 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.2 | 0.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 4.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.2 | 0.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 4.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 1.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 3.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 3.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 0.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 1.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 0.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.4 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.2 | 1.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 2.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 0.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 0.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 1.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 1.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 2.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 0.2 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.2 | 1.3 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.2 | 2.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 1.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 0.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 4.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 1.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 0.6 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 2.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 3.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 1.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 1.7 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 1.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 6.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 2.0 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 3.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 0.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 2.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.2 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.3 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 1.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 1.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 2.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.3 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 2.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.6 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 1.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.9 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.9 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.9 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 1.3 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.1 | 0.3 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.1 | 0.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 2.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 3.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.7 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 3.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.7 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 1.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.5 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.7 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 1.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 6.0 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.0 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 1.0 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.2 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 1.3 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.5 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 2.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.8 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.9 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 1.9 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.0 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 1.0 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.0 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.1 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.7 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.6 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 4.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 5.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 3.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 5.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 5.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 0.7 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 2.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 4.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 2.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 1.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 3.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 3.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 3.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 3.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 2.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 2.4 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 4.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.6 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 2.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 2.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.0 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 10.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 7.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 10.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 11.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 4.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 3.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.4 | 4.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 7.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.4 | 4.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.3 | 0.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.3 | 6.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 3.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 1.6 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 1.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 1.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 2.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 0.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 13.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 1.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 1.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 1.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 1.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 0.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 2.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 1.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 3.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 2.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 2.0 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 2.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 2.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.5 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.1 | 0.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 1.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 1.3 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.5 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 2.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.5 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 1.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 2.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.7 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 1.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.0 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 1.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.0 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |